Pathstone Family Office’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
Pathstone Family Office's OGN Position: Q3 2023 in Review
Pathstone Family Office increased its Organon & Co (OGN) stake by 90% in Q3 2023, buying an estimated $235K and bringing the position to 23,823 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.
Pathstone Family Office first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $109M in Q4 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.
- Pathstone Family Office held 23,823 shares of Organon & Co worth $415K as of Q3 2023.
- Pathstone Family Office bought 11,269 Organon & Co shares in Q3 2023, an estimated $235K.
- Organon & Co made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1134 holding.
- Pathstone Family Office first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
- Pathstone Family Office's Organon & Co position peaked at $109M in Q4 2022.
- 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.